Abstract:Gut microbiota is a complex system of organisms, mainly different bacterial species, the gut microbiota interacts with the host, affects host systems and organs (e.g. the brain) and modulates the host physiological functions. The interaction between the gut microbiota and the brain, famously known as gut‐brain axis is a bidirectional connection via neural, immune, and endocrine pathways.IntroductionObesity is a major health problem that is associated with many physiological and mental disorders, such as diabetes, stroke, and depression. Gut microbiota has been affirmed to interact with various organs, including the brain. Intestinal microbiota and their metabolites might target the brain directly via vagal stimulation or indirectly through immune‐neuroendocrine mechanisms, and they can regulate metabolism, adiposity, homoeostasis and energy balance, and central appetite and food reward signaling, which together have crucial roles in obesity. Studies support the concept of bidirectional signaling within the gut–brain axis (GBA) in the pathophysiology of obesity, mediated by metabolic, endocrine, neural, and immune system mechanisms.Materials and methodsScopus, PubMed, Google Scholar, and Web of Science databases were searched to find relevant studies.ResultsThe gut–brain axis (GBA), a bidirectional connection between the gut microbiota and brain, influences physiological function and behavior through three different pathways. Neural pathway mainly consists of the enteric nervous system (ENS) and vagus nerve. Endocrine pathway, however, affects the neuroendocrine system of the brain, particularly the hypothalamus–pituitary–adrenal (HPA) axis and immunological pathway. Several alterations in the gut microbiome can lead to obesity, by modulating metabolic pathways and eating behaviors of the host through GBA. Therefore, novel therapies targeting the gut microbiome, i.e., fecal microbiota transplantation and supplementation with probiotics and prebiotics, can be a potential treatment for obesity.ConclusionThis study corroborates the effect of gut microbiome on physiological function and body weight. The results show that the gut microbiota is becoming a target for new antiobesity therapies.

The Microbiota and the Gut–Brain Axis in Controlling Food Intake and Energy Homeostasis

Obesity and the gut microbiota: implications of neuroendocrine and immune signaling

Interplay Between the Gut-Brain Axis, Obesity and Cognitive Function

From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?

The Role of the Gut Microbiota in the Gut–Brain Axis in Obesity: Mechanisms and Future Implications

Gut microbiota in obesity and metabolic disorders

Obesity Affects the Microbiota–Gut–Brain Axis and the Regulation Thereof by Endocannabinoids and Related Mediators

Gut microbes and food reward: From the gut to the brain

Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut–liver axis

Importance of gut microbiota in obesity

The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease

Prebiotics to manage the microbial control of energy homeostasis

Gut Microbiota and Obesity: Focus on Hormone Regulation and Appetite Control

The Gut-Brain Axis, the Human Gut Microbiota and Their Integration in the Development of Obesity

Gut-Brain Cross-Talk in Metabolic Control

Dietary Fat Modulation of Gut Microbiota and Impact on Regulatory Pathways Controlling Food Intake

Obesity and gut–microbiota–brain axis: A narrative review

The microbiome-gut-brain axis in nutritional neuroscience

The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective

The gut microbiota in obesity and weight management: microbes as friends or foe?

Understanding the role of the human gut microbiome in overweight and obesity